• OncologyTube
    • 0
      • Title
        User LIVE NOW
      • Logo LIVE NOW
        Title
        User
      • Schedule An Interview
        • Schedule A Remote Interview with OncologyTube
    • Home
    • Trending

    • Sign In

    • Audios and Videos
    • Videos
    • Audios

    • Channels

    • Browse Channels

    • Categories

    • Acute Lymphoblastic Leukemia 5648
    • Acute Myelogenous Leukemia 202
    • Bladder Cancer 71
    • Bone Metastases 2
    • Brain Cancer 59
    • Breast Cancer 233
    • Business Management 3
    • Cervical Cancer 6
    • Chronic Lymphocytic Leukemia 192
    • Chronic Myelogenous Leukemia 43
    • Colorectal Cancer 110
    • COVID-19 27
    • Gastrointestinal Cancer 93
    • General 320
    • Head and Neck Cancers 74
    • Hematologic Malignancies 180
    • Hodgkin Lymphoma 28
    • Immunotherapy 155
    • Kidney Cancer 376
    • Liver Cancer 25
    • Lymphoma 180
    • Melanoma and Skin Cancer 57
    • Multiple Myeloma 466
    • Myeloproliferative Disease 20
    • News 148
    • Non-Hodgkin Lymphoma 77
    • Non-Small Cell Lung Cancer 413
    • Other 256
    • Ovarian Cancer 43
    • Pancreatic Cancer 73
    • Patient Resources 28
    • Pediatric Cancer 3
    • Prostate Cancer 225
    • Sickle Cell 21
    • Small Cell Lung Cancer 72
    • Soft Tissue Sarcoma 10
    • Supportive Care 47
    • Testicular Cancer 3
    • Urology 14
    • Uterine Cancer 7

    • About
    • Contact
    Cellular therapy and drug access for viral lymphomas
    00:09:56

    Cellular therapy and drug access for viral lymphomas

    Cell-based therapies are an exciting area across the board in oncology. Here, our experts discuss the use of cellular therapy for viral lymphomas, in a discussion chaired by Catherine Bollard, MBChB, MD, FRACP, FRCPA, of the Children's National Health System, Washington, DC. Joining the discussion are Ruth Jarrett, MD, PhD, from the University of Glasgow Center for Virus Research, Glasgow, UK, Mark Roschewski, MD, of the National Cancer Institute, Bethesda, MD, and Richard Little, MD, of the National Cancer Institute, Rockville, MD. The need for improved drug access in developing countries is highlighted by the experts, as well as the need to therapeutically target EBNA1. This video was recorded at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France.

    6 Views
    2 years ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Suggested

    Trending

    ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
    00:03:24

    ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma

    Free
    213 Views
    1 year ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
    00:02:59

    CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting

    Free
    236 Views
    1 year ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
    00:08:45

    CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib

    Free
    141 Views
    1 year ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Chronic Lymphocytic Leukemia,  Non-Hodgkin Lymphoma, Should all HL patients be treated the same
    00:03:44

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same

    Free
    120 Views
    1 year ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    • 1 (current)
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10

    Non-Hodgkin Lymphoma

    Danelle James, M.D. @Pharmacyclics #WalenstromsMacroglobulinemia #Non-HodgkinsLymphoma #iNNOVATE #Cancer #Research Ibrutinib U.S. Prescribing Information Updated to Include Long-Term Data... Danelle James, M.D. @Pharmacyclics #WalenstromsMacroglobulinemia #Non-HodgkinsLymphoma #iNNOVATE #Cancer #Research Ibrutinib U.S. Prescribing Information Updated to Include Long-Term Data...
    00:09:15

    Danelle James, M.D. @Pharmacyclics #WalenstromsMacroglobulinemia #Non-HodgkinsLymphoma #iNNOVATE #Cancer #Research Ibrutinib U.S. Prescribing Information Updated to Include Long-Term Data...

    Free
    22 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Mazyar Shadman, M.D., M.P.H.@mshadman @fredhutch #Non-HodgkinLymphoma #Cancer #Research Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Mazyar Shadman, M.D., M.P.H.@mshadman @fredhutch #Non-HodgkinLymphoma #Cancer #Research Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy
    00:11:34

    Mazyar Shadman, M.D., [email protected] @fredhutch #Non-HodgkinLymphoma #Cancer #Research Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy

    Free
    44 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Rajat Bannerji, MD, Ph.D. @RutgersCancer #ASH20 #NonHodgkinLymphoma #Cancer #Research 400 Odronextamab (REGN1979) Rajat Bannerji, MD, Ph.D. @RutgersCancer #ASH20 #NonHodgkinLymphoma #Cancer #Research 400 Odronextamab (REGN1979)
    00:19:13

    Rajat Bannerji, MD, Ph.D. @RutgersCancer #ASH20 #NonHodgkinLymphoma #Cancer #Research 400 Odronextamab (REGN1979)

    Free
    16 Views
    2 months ago
    ASHReport
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
    0:07:00

    Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL

    Free
    142 Views
    5 months ago
    AACR
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber
    0:05:32

    Caron Jacobson, MD on Interim Analysis of ZUMA-5 #ASCO2020 @DanaFarber

    Free
    8 Views
    7 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
    0:02:15

    John Kuruvilla, MD on A New Standard in Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO

    Free
    10 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
    0:02:51

    John Kuruvilla, MD on the Specific of the Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO

    Free
    35 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    John Kuruvilla, MD on KEYNOTE-204: Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO John Kuruvilla, MD on KEYNOTE-204: Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO
    0:01:27

    John Kuruvilla, MD on KEYNOTE-204: Phase II Study of Pembrolizumab vs. Brentuximab #ASCO2020 @ClevelandClinic #ASCO

    Free
    27 Views
    9 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Eyal Lebel, MD on Recurrence of Cutaneous Anaplastic Large Cell Lymphoma Eyal Lebel, MD on Recurrence of Cutaneous Anaplastic Large Cell Lymphoma
    0:02:13

    Eyal Lebel, MD on Recurrence of Cutaneous Anaplastic Large Cell Lymphoma

    Free
    31 Views
    10 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Zachary Frosch, MD on Needing More Prospective Data in Aggressive B-Cell Lymphoma @PennMedicine #lymphoma Zachary Frosch, MD on Needing More Prospective Data in Aggressive B-Cell Lymphoma @PennMedicine #lymphoma
    0:01:56

    Zachary Frosch, MD on Needing More Prospective Data in Aggressive B-Cell Lymphoma @PennMedicine #lymphoma

    Free
    26 Views
    10 months ago
    Penn Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Zachary Frosch, MD on Molecular Risk of Stratification: How is it Validated? @PennMedicine #lymphoma Zachary Frosch, MD on Molecular Risk of Stratification: How is it Validated? @PennMedicine #lymphoma
    0:01:04

    Zachary Frosch, MD on Molecular Risk of Stratification: How is it Validated? @PennMedicine #lymphoma

    Free
    18 Views
    10 months ago
    Penn Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Zachary Frosch, MD on Molecular Risk of Stratification in B-Cell Lymphoma @PennMedicine #lymphoma Zachary Frosch, MD on Molecular Risk of Stratification in B-Cell Lymphoma @PennMedicine #lymphoma
    0:01:29

    Zachary Frosch, MD on Molecular Risk of Stratification in B-Cell Lymphoma @PennMedicine #lymphoma

    Free
    28 Views
    10 months ago
    Penn Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    • 1 (current)
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7

    Copyright 2020 Medicus Networks, Inc. 27574 Commerce Center Drive, Suite 236, Temecula, CA 92592